Ethnic differences in intrahepatic lipid and its association with hepatic insulin sensitivity and insulin clearance between men of Black and White ethnicity with early type 2 diabetes by Hakim, Olah et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1111/dom.13771
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Hakim, O., Bello, O., Bonadonna, R. C., Mohandas, C., Shojee-moradie, F., Jackson, N., ... Goff, L. (2019).
Ethnic differences in intrahepatic lipid and its association with hepatic insulin sensitivity and insulin clearance
between men of Black and White ethnicity with early type 2 diabetes. DIABETES OBESITY AND METABOLISM,
21(9), 2163-2168. https://doi.org/10.1111/dom.13771
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
1 
 
Ethnic differences in intrahepatic lipid and its association with hepatic insulin sensitivity 1 
and insulin clearance between men of Black and White ethnicity with early type 2 2 
diabetes 3 
 4 
Short title: Ethnicity, hepatic fat and type 2 diabetes 5 
 6 
Olah Hakim1, Oluwatoyosi Bello1, Riccardo C. Bonadonna2, Cynthia Mohandas1, Fariba 7 
Shojee-Moradie3, Nicola Jackson3, Linda Boselli4, Brandon Whitcher5, Haris Shuaib6,7, K. 8 
George M.M. Alberti1, Janet L. Peacock8, A. Margot Umpleby3, Geoff Charles-Edwards6,9, 9 
Stephanie A. Amiel1, Louise M. Goff1 10 
 11 
1Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences & 12 
Medicine, King’s College London, London, UK; 2Department of Medicine & Surgery, 13 
University of Parma and Azienda Ospedaliera Universitaria di Parma, Parma, Italy; 3Faculty 14 
of Health and Medical Sciences, University of Surrey, Guildford, UK; 4Division of 15 
Endocrinology and Metabolic Disease, University of Verona School of Medicine, Verona, 16 
Italy; 5Research Centre for Optimal Health, School of Life Sciences, University of 17 
Westminster, London, UK; 6Medical Physics, Guy’s & St Thomas’ NHS Foundation Trust, 18 
London, UK; 7Institute of Psychiatry, Psychology & Neuroscience, King’s College London, 19 
London, UK; 8School of Population Health and Environmental Sciences, King’s College 20 
London, London, UK; 9School of Biomedical Engineering & Imaging Sciences, King’s 21 
College London, London, UK 22 
 23 
Corresponding author: Dr. Louise M. Goff, Diabetes Research Group, Departments of 24 
Diabetes & Nutritional Sciences, School of Life Course Sciences, Faculty of Life Sciences & 25 
2 
 
Medicine, King’s College London, Waterloo Campus, Franklin-Wilkins Building, Room 3.87, 26 
London, SE1 9NH, United Kingdom. T: +44 (0)20 7848 6111; E: louise.goff@kcl.ac.uk 27 
Word count: main body 1957, abstract: 187 28 
Tables & Figures: 2 (1 table, 1 figure) 29 
References: 1830 
3 
 
ABSTRACT 31 
Intrahepatic lipid (IHL) is linked with reduced hepatic insulin sensitivity and insulin clearance. 32 
Despite their high risk for type 2 diabetes (T2D), there have been limited investigations of these 33 
relationships in Black populations. We investigated these relationships in 18 White European 34 
(WE) and 18 Black West African (BWA) men with T2D <5 years. They underwent magnetic 35 
resonance imaging to quantify IHL, a hyperinsulinemic-euglycemic clamp with [6,6 2H2] 36 
glucose infusion to assess hepatic insulin sensitivity and a hyperglycemic clamp to assess 37 
insulin clearance. BWA men had lower IHL than WE men (3.7 (5.3) vs 6.6 (10.6) %, p=0.03). 38 
IHL was inversely associated with basal hepatic insulin sensitivity in WE but not BWA men 39 
(BWA: r=-0.01, P=0.96; WE: r=-0.72, P=0.006) with a significant interaction by ethnicity 40 
(Pinteraction=0.05), however, IHL was not associated with % suppression of endogenous glucose 41 
production by insulin in either ethnicity. IHL showed a trend to an association with insulin 42 
clearance in BWA only (BWA: r=-0.42, P=0.09; WE: r=-0.14, P=0.58). The lack of association 43 
between IHL and hepatic insulin sensitivity in BWA men indicates IHL may play a lesser 44 
detrimental role in T2D in BWA men. 45 
 46 
KEY WORDS: Ethnicity, hepatic fat, insulin sensitivity, insulin clearance, African, 47 
lipotoxicity  48 
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ABBREVIATIONS 49 
ALT: Alanine aminotransferase 50 
BSA: Body surface area 51 
BWA: Black West African  52 
HbA1C: Glycated hemoglobin 53 
IHL: Intrahepatic lipids 54 
MRI: Magnetic resonance imaging 55 
SAT: Subcutaneous adipose tissue 56 
VAT: Visceral adipose tissue 57 
WE: White European  58 
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INTRODUCTION 59 
Black populations are disproportionately affected by type 2 diabetes (T2D) with 2-3 times 60 
greater prevalence compared to white populations1 despite typically having lower intrahepatic 61 
lipids (IHL) and visceral adipose tissue (VAT)1,2. IHL is usually elevated in individuals with 62 
T2D and is inversely associated with both hepatic insulin sensitivity and insulin clearance3. 63 
Consistently, insulin clearance has been shown to be lower in Black populations compared to 64 
White populations4. However, investigations of ethnic differences in hepatic insulin sensitivity 65 
have shown inconsistent findings5-7. We have previously reported similar hepatic insulin 66 
sensitivity but lower insulin clearance in Black West African (BWA) compared to White 67 
European (WE) men8,9. Despite the literature reporting ethnic differences in IHL, hepatic 68 
insulin sensitivity, and insulin clearance between Black and White populations, these have not 69 
previously been investigated in a single study to understand their relationships and how 70 
ethnicity impacts on these in the development of T2D in Black populations. Therefore, our aim 71 
was to investigate ethnic differences in IHL and its relationship with hepatic insulin sensitivity 72 
and insulin clearance in BWA and WE men with early T2D. 73 
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METHODS 74 
This investigation was conducted as part of the South London Diabetes and Ethnicity 75 
Phenotyping study (Soul-Deep)10. Data on metabolic parameters for 92% of the present cohort 76 
have been previously reported8,9, the present analyses relate to the whole cohort in whom 77 
relevant data were available. Participant recruitment and data collection took place April 2013 78 
to January 2015. The study was approved by the London Bridge National Research Ethics 79 
Committee (12/LO/1859); all participants provided written informed consent. 80 
Participants 81 
Participants were recruited from primary care practices in London and deemed eligible to 82 
participate if they were 1) 18-65 years old, 2) BMI of 25-40 kg/m2, 3) self-reported WE or 83 
BWA ethnicity, 4) diagnosis of T2D (less than 5 years), and 5) treated with lifestyle and/or 84 
metformin only. Further details of eligibility criteria are published in the protocol10. 85 
Participants attended all assessments after an overnight fast. If on metformin, participants were 86 
instructed to cease taking it for 7-days prior to each visit. Physical activity was measured as 87 
hours per day of moderate intensity activity using accelerometry watches worn for 4 88 
consecutive days (MotionWatch 8.0, CamTech). 89 
Magnetic Resonance Imaging 90 
A Dixon-based MRI sequence was used on a 1.5 Tesla Siemens scanner to obtain images for 91 
the quantification of IHL and VAT. Participants were scanned lying supine on a spine RF coil 92 
with body phased array RF coils placed over the chest, abdomen and pelvis. While abdominal 93 
images were acquired participants were instructed to complete three 17-second breath-holds. 94 
From each participant, contiguous, axial T1-weighted gradient-echo images (repetition time: 95 
6.77ms; echo times: 4.77ms (in-phase), 2.39ms (out-of-phase), flip angle: 10°) each with a 96 
slice thickness of 3mm were acquired, from which water and fat images were produced. Images 97 
were analyzed using HOROS v1.1.7 (www.horosproject.org; accessed 21/10/2017). IHL was 98 
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measured by selecting two abdominal MRI images representing the superior and inferior parts 99 
of the liver. Four circular regions of interest (ROIs) in identical positions were placed within 100 
the liver tissue of each pair of water and fat images (supplementary material, Figure 1). ROIs 101 
were positioned to include the posterior, anterior, medial and lateral sections of the liver. ROI 102 
areas ranged from 20 to 30cm2, intending to cover as large an area of liver as possible while 103 
avoiding blood vessels, bile ducts and artefacts. Using the formula: %IHL = (F/(F+W))*100, 104 
where F is the pixel signal intensity of the fat image and W is the pixel signal intensity of the 105 
water image, the hepatic fat fraction was calculated in each ROI and IHL was calculated as the 106 
mean of all 8 ROIs. Total abdominal VAT and body SAT (neck to knee, excluding arms) was 107 
determined using an automated MRI analysis technique (Klarismo Ltd., London, UK) as 108 
previously described11. 109 
Clamp assessments 110 
Whole-body insulin sensitivity (M-value) during the high dose insulin infusion (40 mU m-2 111 
BSA min-1), hepatic insulin sensitivity (% suppression of endogenous glucose production 112 
(EGP) during the low dose insulin infusion (10 mU m-2 BSA min-1) and basal hepatic insulin 113 
sensitivity index) were measured using a two-step hyperinsulinemic-euglycemic clamp with 114 
the infusion of [6,6 2H2] glucose, according to previously described methodology
9.  The basal 115 
hepatic insulin sensitivity index was calculated as the reciprocal of the product of basal EGP 116 
rate (mmol/BSA min-1) and fasting insulin concentration (pmol/l). To assess and model insulin 117 
clearance, each participant underwent a hyperglycemic clamp, described in detail elsewhere8. 118 
Statistical analysis 119 
Ethnic differences were determined using independent samples t-test for normally distributed 120 
variables or a Mann-Whitney test for variables that could not be log transformed to normal. 121 
ANCOVA was used, with VAT, BMI and age as separate covariates, to investigate ethnic 122 
differences in IHL and VAT. Correlations were assessed using Pearson’s correlation; partial 123 
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correlation was used to investigate associations while adjusting for VAT, BMI and age. 124 
Significance of an interaction by ethnicity was assessed using multiple regression with 125 
ethnicity*logIHL used as an interaction term. Analyses were conducted with SPSS version 126 
25.0; P≤ 0.05 were considered statistically significant.127 
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RESULTS 128 
Participant characteristics 129 
The 18 BWA and 18 WE men were well-matched for age and BMI, Table 1. The BWA men 130 
had significantly lower IHL and total VAT mass, Table 1 (Figure 2, supplementary data). After 131 
adjustment for BMI, the ethnic differences in VAT remained significant (P=0.008) but not for 132 
IHL (P=0.18). After adjustment for VAT, there were no ethnic differences in IHL (WE: 6.07 133 
(SE 1.16) vs BWA: 5.56 (SE 1.16) %, P=0.70).  Non-alcoholic fatty liver disease, defined as 134 
liver fat above 5% determined by Dixon-MRI12, was present in 33% of BWA men compared 135 
to 67% of WE men (P=0.047).  136 
Metabolic characteristics 137 
There were no ethnic differences in whole-body insulin sensitivity (M-value) or hepatic insulin 138 
sensitivity, expressed as % suppression of EGP during the low dose insulin infusion, Table 1; 139 
consistent with earlier findings we reported from a smaller sample from this cohort9. However, 140 
there was a trend towards higher basal hepatic insulin sensitivity index in the BWA men, Table 141 
1. Insulin clearance was not different between the BWA and WE men (Table 1), again 142 
consistent with our earlier report8. 143 
Relationships between IHL and insulin sensitivity 144 
Relationships between IHL and the measures of insulin sensitivity are presented in Figure 1 145 
(A, B and C). The inverse associations between IHL and both whole-body insulin sensitivity 146 
(M-value) and basal hepatic insulin sensitivity reached statistical significance in only the WE 147 
men. In multiple regression analysis a significant ethnicity interaction was found in the 148 
relationship between IHL and basal hepatic insulin sensitivity (Pinteraction=0.05); no other 149 
significant ethnicity interactions were found. There were no changes in the associations after 150 
adjustment for VAT, BMI or age except for the relationship between IHL and M-value which 151 
reduced in significance in WE men after adjustment for BMI (P=0.13) (supplementary data). 152 
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Relationships between IHL and insulin clearance 153 
Relationships between IHL and insulin clearance, are presented in Figure 1 (D). IHL was 154 
inversely associated with insulin clearance, which neared significance, in BWA but not WE 155 
men; partial correlation adjusting for VAT reduced the significance of this relationship (BWA: 156 
r=-0.41, P=0.11; WE: r=-0.29, P=0.27); no significant ethnicity interaction was found 157 
(Pinteraction=0.40).158 
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CONCLUSIONS 159 
In this study of White European and Black West African men with early T2D, we investigated 160 
ethnic differences in hepatic fat and its relationship with hepatic insulin sensitivity and insulin 161 
clearance. Consistent with published data13, BWA men had lower IHL and VAT. We found 162 
additional ethnic differences in relationships between IHL and hepatic insulin sensitivity and 163 
insulin clearance whereby in WE men, IHL was inversely related to basal hepatic insulin 164 
sensitivity and whole-body insulin sensitivity, which was not the case in BWA men. In BWA 165 
men we found a trend towards an inverse relationship between IHL and insulin clearance which 166 
was not found in the WE men. Our findings suggest that IHL is implicated in the metabolic 167 
derangements of the liver in T2D differently according to ethnicity. To our knowledge, this is 168 
the first study to investigate relationships between IHL and insulin clearance in a Black 169 
population; the trend towards an inverse relationship in BWA but not WE men suggests that 170 
the reduction of insulin clearance may be modulated differently depending on ethnicity.  171 
Despite relationships between IHL and whole-body insulin resistance being commonly 172 
reported, the mechanisms that link the two are less understood. Current investigations show an 173 
excess of liver fat leads to accumulation of lipid intermediates causing hepatic mitochondrial 174 
dysfunction, inflammation and increased VLDL-TAG production which may result in hepatic 175 
and systemic insulin resistance14. Our finding of IHL being inversely associated with basal 176 
hepatic insulin sensitivity and whole-body insulin sensitivity which reached significance in 177 
WE but not BWA men may indicate the above detrimental effects of lipid intermediates 178 
occurring to a greater extent in WE men.  179 
There was no relationship between IHL and suppression of EGP in either ethnic group. This 180 
could indicate a decreased effect of IHL on hepatic insulin sensitivity in the insulin stimulated 181 
state compared to the basal state in WE men. To our knowledge only one other study has 182 
investigated the relationship between IHL and hepatic insulin sensitivity using the 183 
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hyperinsulinemic-euglycemic clamp with infusion of isotopically labelled glucose6; they found 184 
that IHL was associated with hepatic insulin sensitivity in obese Black South African women 185 
but not in obese White South African women, which contradicts our findings. There are several 186 
potential explanations for this, such as glycemic state; our study included participants with 187 
T2D whereas the South African women were normal glucose tolerant. The disparities may also 188 
be due to gender differences as there is consistent evidence demonstrating that the phenotype 189 
of T2D differs by gender within populations of African descent15.  190 
The presence of NAFLD was comparable to that reported in other large multi-ethnic cohorts16 191 
and was significantly lower in the BWA men. One of the main theories that explains how IHL 192 
accumulates is the “portal theory”, which states that excess VAT releases free fatty acids 193 
directly into the portal vein, subsequently depositing as IHL17. Our study may support the portal 194 
theory as after adjustment for VAT, IHL no longer differed by ethnicity, suggesting that the 195 
lower IHL in BWA men may be driven by lower VAT. Indeed, ethnic differences in the 196 
mechanisms of SAT expansion may explain the differences we found in VAT as others have 197 
suggested18; however, we did not directly measure adipogenesis in our study which may be an 198 
implication for further research.  199 
The strengths of this study include the use of the rigorous hyperinsulinemic-euglycemic clamp 200 
method combined with the infusion of [6,6 2H2] glucose to determine both whole-body and 201 
hepatic insulin sensitivity. However, our study is not without its limitations. Our sample size 202 
is relatively small; in these secondary analyses we may not have sufficient power to reliably 203 
detect ethnic differences. Our measurement of insulin clearance does not differentiate hepatic 204 
from extrahepatic insulin clearance, rather it is a measure of whole-body insulin clearance. 205 
However, it has been shown that approximately 80% of endogenous insulin is degraded in the 206 
liver 3. Our WE men had greater statin use which may have resulted in lower hepatic fat 207 
accumulation and reduced the ethnic discrepancies due to the lipid lowering effects of statins. 208 
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Another limitation is studying only men with T2D, however previous studies have mostly 209 
focused on women, due to the greater prevalence of T2D in Black women compared to men. 210 
Our study redresses this.  211 
In conclusion, our study demonstrates ethnic differences in the relationships between IHL and 212 
metabolic parameters of the liver. The lack of inverse association between IHL and basal 213 
hepatic insulin sensitivity in the BWA men, found in the WE men, suggests that fasting hepatic 214 
insulin resistance occurs independently of IHL in BWA men. However, the reduction of insulin 215 
clearance may be influenced by IHL more so in Black men with T2D compared to White men.216 
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Table 1: Clinical and metabolic characteristics of Black West African and White 254 
European men 255 
Data presented as mean ± SD or geometric mean (95% CI) for log transformed data (‡) or median (interquartile 256 
range) for non-parametric data (†) or number of participants for ordinal data (§). P values determined using 257 
independent samples t-tests for normally distributed data, Mann-Whitney test for non-parametric data or chi-258 
 
BWA 
(n=18) 
WE 
(n=18) 
P 
Age (years)† 54.9 (9.3) 58.5 (6.3) 0.67 
Weight (kg)  92.3 ± 12.3 99.8 ± 16.7 0.14 
BMI (kg/m2)  29.8 ± 3.5 31.5 ± 4.1 0.18 
Waist circumference (cm)  104.9 ± 10.2 111.9 ± 13.0 0.08 
SAT (neck to knee) (kg)a‡ 12.6 (10.5-15.2) 14.6 (12.2-17.6) 0.24 
VAT, total (kg)a 3.99 ± 1.54 6.09 ± 2.46 0.006 
IHL (%)† 3.7 (5.3) 6.6 (10.6) 0.03 
Diabetes duration (years)† 3.0 (2.2) 3.0 (1.3) 0.42 
Statin use§ 10/18 16/18 0.026 
Fasting glucose (mmol/l) 6.63 ± 0.67 6.88 ± 1.38 0.50 
HbA1c (%) 6.67 ± 0.68 6.64 ± 0.70 0.90 
ALT‡ (IU/l) 26.7 (21.8-32.5) 31.2 (25.7-37.7) 0.24 
Systolic BP (mm Hg) 136.7 ± 13.8 130.9 ± 14.2 0.22 
Diastolic BP (mm Hg)† 89.0 (8.7) 83.0 (12.5) 0.06 
Total cholesterol (mmol/l) 4.11 ± 0.73 4.27 ± 0.70 0.50 
LDL-cholesterol (mmol/l) 2.32 ± 0.56 2.28 ± 0.66 0.85 
HDL-cholesterol (mmol/l) 1.18 ± 0.38 1.19 ± 0.25 0.92 
Triglyceride (mmol/l)† 1.05 (0.70) 1.60 (1.25) 0.03 
Moderate activity time (hours/day)c 2.1 ± 0.66 1.9 ± 0.90 0.74 
Metabolic characteristics    
M value (mg/m2 BSA min-1)d 162.0 ± 75.0 128.5 ± 63.7 0.17 
Hepatic basal insulin sensitivity index 
((mmol/m2 BSA min pmol l)-1)e 
68.0 ± 24.6 49.1 ± 29.4 0.09 
Suppression of endogenous glucose 
production (%)e 
37.9 ± 19.5 34.7 ± 20.7 0.70 
Average insulin clearance (mL/m2 BSA 
min-1)† 
732.8 (505.7) 814.6 (450.2) 0.61 
17 
 
squared test for ordinal data.  N for aWE=17, BWA=17; bWE=17, BWA=16; cWE=10, BWA=7; dWE=18, 259 
BWA=16; eWE=12, BWA=14. 260 
Abbreviations: ALT, alanine aminotransferase; BP, blood pressure; BWA, Black West African; HbA1c, glycated 261 
hemoglobin; HDL, high density lipoprotein; IHL, intrahepatic lipid; LDL, low density lipoprotein; SAT, 262 
subcutaneous adipose tissue; VAT, visceral adipose tissue; WE, White European.263 
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 264 
Figure 1: Relationships between hepatic fat fraction and (A) hepatic insulin sensitivity index 265 
(basal) ((mmol/m2 BSA min pmol l)-1), (B) suppression of hepatic glucose production (%), (C) 266 
whole-body insulin sensitivity (M-vlaue) (mg/m2 BSA min-1), and (D) insulin clearance (mL/m2 267 
BSA min-1) in WE and BWA men. Relationships between hepatic insulin clearance and (E) 268 
suppression of endogenous glucose production, and (F) hepatic insulin sensitivity index (basal) 269 
in WE and BWA men. Black circles with dotted line = BWA men, white circles with solid line 270 
= WE men.271 
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Supplementary data: 
 
Table 1: Pearson’s correlation and partial correlation coefficients showing relationships 
between hepatic fat fraction and measures of insulin sensitivity and insulin clearance in white 
European and black West African men 
 
 
 WE BWA 
 r p r p 
M-Value -0.64 0.004 -0.35 0.18 
Adjusted for age -0.07 0.003 -0.39 0.15 
Adjusted for BMI -0.38 0.13 -0.05 0.85 
Adjusted for VAT -0.56 0.02 -0.06 0.85 
Hepatic insulin sensitivity index -0.72 0.006 -0.01 0.96 
Adjusted for age -0.70 0.01 -0.12 0.96 
Adjusted for BMI -0.60 0.04 -0.16 0.60 
Adjusted for VAT -0.73 0.01 0.35 0.26 
% Suppression of endogenous 
glucose production 
-0.11 0.73 -0.34 0.23 
Adjusted for age -0.12 0.72 -0.51 0.07 
Adjusted for BMI -0.04 0.91 -0.21 0.50 
Adjusted for VAT -0.03 0.93 -0.02 0.95 
Insulin clearance -0.14 0.58 -0.42 0.09 
Adjusted for age -0.15 0.57 -0.44 0.07 
Adjusted for BMI 0.14 0.59 -0.27 0.29 
Adjusted for VAT -0.29 0.27 -0.41 0.11 
Abbreviations: BMI, body mass index; BWA, black West African; VAT, visceral adipose tissue; WE, 
white European  
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 27 
Figure 1: Quantification of intrahepatic lipids by selection of two axial MRI images with 28 
regions of interest positioned on the right and left lobes of the liver as well as the posterior, 29 
anterior, medial and lateral sections. 30 
Panel A shows a coronal MRI image with the horizontal line depicting the position of axial 31 
images C and D. Panel B shows a coronal MRI image with the horizontal line depicting the 32 
position of axial images E and F. Panel C shows 4 circular regions of interest on an axial 33 
abdominal MRI water image on the superior section of the liver. Panel D shows the axial 34 
abdominal MRI fat image that corresponds to image C with 4 identical regions of interest. 35 
Panel E shows 4 circular regions of interest on an axial abdominal MRI water image on the 36 
inferior section of the liver. Panel F shows the axial abdominal MRI fat image that corresponds 37 
to image E with 4 identical regions of interest. 38 
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 40 
Figure 2: Boxplot of hepatic fat fraction in White European (WE) and Black West African 41 
men (BWA) with early type 2 diabetes matched for both age and BMI 42 
 43 
